Charles H. Randall's Insider Trades & SAST Disclosures

Charles H. Randall's most recent trade in SAB Biotherapeutics Inc was a trade of 145,681 Earnout Rights (Restricted Stock Units) done . Disclosure was reported to the exchange on Oct. 22, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
SAB Biotherapeutics Inc
Charles H. Randall Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 145,681 145,681 - - Earnout Rights (Restricted Stock Units)
SAB Biotherapeutics Inc
Charles H. Randall Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 116,321 116,321 - - Employee Stock Option (right to buy)
SAB Biotherapeutics Inc
Charles H. Randall Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 116,321 116,321 - - Employee Stock Option (right to buy)
SAB Biotherapeutics Inc
Charles H. Randall Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 116,321 116,321 - - Employee Stock Option (right to buy)
SAB Biotherapeutics Inc
Charles H. Randall Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 11,632 11,632 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades